Renal Cancer - Results from #3020

MiR-22 functions as a biomarker and regulates cell proliferation, cycle, apoptosis, migration and invasion in renal cell carcinoma. January 27, 2020

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor. January 24, 2020

Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging. January 24, 2020

MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2. January 24, 2020

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma. January 23, 2020

HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. January 23, 2020

MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2. January 23, 2020

Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans. January 23, 2020

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma. January 23, 2020

Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. January 22, 2020

A historical turning point for the treatment of advanced renal cell carcinoma: ınhibition of ımmune checkpoint. January 22, 2020

Characterisation of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing. January 22, 2020

Computed Tomography Imaging Characteristics of Histologically Confirmed Papillary Renal Cell Carcinoma-Implications for Ancillary Imaging. January 21, 2020

Renal Neuroendocrine Neoplasms: A Single-center Experience. January 21, 2020

Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma. January 21, 2020

A Near Infrared-Peptide Probe with Tumor-Specific Excretion Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma. January 20, 2020

TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma. January 20, 2020

Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines. January 20, 2020

Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma. January 17, 2020

Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. January 17, 2020

Page 152 of 456